# Efficacy and Safety of Oral NOMAC-E2 in Indian Women (P07057/MK-8175A-017)

> **NCT01723579** · PHASE3 · WITHDRAWN · sponsor: **Organon and Co**

## Conditions studied

- Contraception

## Interventions

- **DRUG:** Nomegestrol acetate (NOMAC)
- **DRUG:** Estradiol (E2)

## Key facts

- **NCT ID:** NCT01723579
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-07
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2022-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01723579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01723579, "Efficacy and Safety of Oral NOMAC-E2 in Indian Women (P07057/MK-8175A-017)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01723579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*